Johnson & Johnson Issues Dr. Paul Janssen Award for Biomedical Research Call for Nominations

 Johnson & Johnson Issues Dr. Paul Janssen Award for Biomedical Research Call
                               for Nominations

PR Newswire

NEW BRUNSWICK, N.J., Jan. 10, 2013

NEW BRUNSWICK, N.J., Jan.10, 2013 /PRNewswire/ --The Dr. Paul Janssen Award
for Biomedical Research today opens its 2013 call for nominations. This
prestigious award recognizes individuals whose scientific research has made,
or has the potential to make, significant transformational contributions
toward the improvement of human health. Nominations will be accepted until
February 28, 2013 at www.pauljanssenaward.com for consideration by an
independent selection committee of world renowned scientists. A $100,000 cash
prize will be awarded to the scientist or group of scientists receiving the
Award.

The Dr. Paul Janssen Award for Biomedical Research honors Dr. Paul Janssen
(1926-2003), who is widely recognized as one of the most productive scientists
of the 20th century. Known throughout the scientific community as "Dr. Paul,"
Janssen was responsible for breakthrough treatments in disease areas including
pain management, psychiatry, infectious disease and gastroenterology, and
founded Janssen Pharmaceutica, N.V., a Johnson & Johnson Company.

"Johnson & Johnson is pleased to recognize the ground-breaking research being
done by dedicated and talented scientists around the world," said Paul
Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman,
Pharmaceuticals, Johnson & Johnson. "Through the Dr. Paul Janssen Award for
Biomedical Research, we honor the inspirational legacy of Dr. Paul, applaud
today's researchers, and recognize the potential of scientific and
technological advances to transform human health."

In 2012, the Award was presented to Victor Ambros, Ph.D., of University of
Massachusetts Medical School, and Gary Ruvkun, Ph.D., of Massachusetts General
Hospital and Harvard Medical School, for their co-discovery of microRNAs as
central regulators of gene expression and development. Their discovery opened
new fields of research and has implications for the development of diagnostic
tools and medicines.

"Scientific innovation has proven its tremendous value to individuals and
society by extending and improving lives," said Dr. Stoffels. "We must
continue to celebrate and reward researchers and innovators whose passion and
ideas help advance new healthcare solutions that address the needs of people
around the world."

Previous Award winners include Napoleone Ferrara, M.D., Genentech Fellow;
Anthony S. Fauci, M.D., director, National Institute of Allergy and Infectious
Diseases (NIAID); Erik De Clercq, M.D., Ph.D., chairman, Department of
Microbiology and Immunology, Medical School at the Catholic University of
Leuven; Axel Ullrich, Ph.D., director, Department of Molecular Biology, Max
Planck Institute of Biochemistry in Germany; Professor Marc Feldmann, FMedSci,
FAA, FRS, and Emeritus Professor Sir Ravinder Maini, FRCP, FMedSci, FRS, of
the Kennedy Institute of Rheumatology, Imperial College London; and Craig
Mello, Ph.D., Nobel Laureate, of the Howard Hughes Medical Institute and
University of Massachusetts Medical School.

Beyond the passion and creativity Dr. Paul Janssen demonstrated in the
laboratory, he also inspired and mentored many young scientific leaders who
went on to great achievements in addressing medical need.

"As in past years, we look forward to selecting a 2013 Dr. Paul Janssen Award
winner(s) from among the nominations of worthy individuals in research
institutions and companies around the world, who has significantly improved
human health through dedication to the advancement of science and medicine,"
said Craig Mello, Ph.D., Howard Hughes Medical Institute Investigator and
Professor, Program in Molecular Medicine, University of Massachusetts Medical
School and 2013 chair of the Dr. Paul Janssen Award Selection Committee.

The 2013 Dr. Paul Janssen Award winner will be announced in spring 2013.

About The Dr. Paul Janssen Award for Biomedical Research
Established by Johnson & Johnson, The Dr. Paul Janssen Award salutes the most
passionate and creative scientists in basic or clinical research whose
scientific achievements have made, or have strong potential to make, a
measurable impact on human health. The Dr. Paul Janssen Award is named for Dr.
Paul Janssen, who founded Janssen Pharmaceutica, N.V., in 1953. Known to his
colleagues as "Dr. Paul," Janssen was one of the 20th century's most gifted
and passionate researchers, a physician-scientist who helped save millions of
lives through his contribution to the discovery and development of more than
80 medicines, four of which remain on the World Health Organization's list of
essential medicines. In 1961, Janssen Pharmaceutica, N.V. joined the Johnson &
Johnson Family of Companies. Janssen's legacy continues to inspire Johnson &
Johnson and its commitment to finding innovative cures for unmet medical
needs. Visit www.pauljanssenaward.com for more information.

About Johnson & Johnson
Caring for the world, one person at a time...inspires and unites the people of
Johnson & Johnson (NYSE: JNJ). We embrace research and science – bringing
innovative ideas, products and services to advance the health and well-being
of people. Our approximately 129,000 employees at more than 250 Johnson &
Johnson companies work with partners in healthcare to touch the lives of over
a billion people every day, throughout the world.

Contact:
Seema Kumar
Johnson & Johnson Services, Inc.
908-218-6460 or skumar10@its.jnj.com

Diane Pressman
Janssen Global Services, LLC
908-927-6171 or dpressm1@its.jnj.com

Frederik Wittock
Janssen Global Services, LLC
+32 14 60 57 24 or fwittock@its.jnj.com

SOURCE Johnson & Johnson

Website: http://www.pauljanssenaward.com
 
Press spacebar to pause and continue. Press esc to stop.